HEADER HYDROLASE 07-MAR-08 2ZJM
TITLE CRYSTAL STRUCTURE OF THE HUMAN BACE1 CATALYTIC DOMAIN IN COMPLEX WITH
TITLE 2 N-[1-(5-CHLORO-2-ISOPROPOXY-3-METHOXY-BENZYL)-PIPERIDIN-4-YL]-2-(4-
TITLE 3 SULFAMOYL-PHENOXY)-ACETAMIDE
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: BETA-SECRETASE 1;
COMPND 3 CHAIN: A;
COMPND 4 FRAGMENT: UNP RESIDUES 43-446;
COMPND 5 SYNONYM: BETA-SITE APP CLEAVING ENZYME 1, BETA-SITE AMYLOID PRECURSOR
COMPND 6 PROTEIN CLEAVING ENZYME 1, MEMBRANE-ASSOCIATED ASPARTIC PROTEASE 2,
COMPND 7 MEMAPSIN-2, ASPARTYL PROTEASE 2, ASP 2, ASP2;
COMPND 8 EC: 3.4.23.46;
COMPND 9 ENGINEERED: YES;
COMPND 10 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: BACE1;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562;
SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3);
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET11A
KEYWDS BACE, SMALL-MOLECULE INHIBITOR, FRAGMENT-BASED DISCOVERY, ALTERNATIVE
KEYWDS 2 SPLICING, ASPARTYL PROTEASE, GLYCOPROTEIN, HYDROLASE, MEMBRANE,
KEYWDS 3 PROTEASE, TRANSMEMBRANE, ZYMOGEN
EXPDTA X-RAY DIFFRACTION
AUTHOR T.J.ALLISON,P.PHAM,M.J.ROMANOWSKI,S.K.MUNSHI
REVDAT 4 16-OCT-24 2ZJM 1 REMARK
REVDAT 3 01-NOV-23 2ZJM 1 REMARK
REVDAT 2 10-NOV-21 2ZJM 1 REMARK SEQADV
REVDAT 1 20-JAN-09 2ZJM 0
JRNL AUTH W.YANG,R.V.FUCINI,B.T.FAHR,M.RANDAL,K.E.LIND,M.B.LAM,W.LU,
JRNL AUTH 2 Y.LU,D.R.CARY,M.J.ROMANOWSKI
JRNL TITL FRAGMENT-BASED DISCOVERY OF NOVEL BACE1 INHIBITORS USING
JRNL TITL 2 TETHERING TECHNOLOGY
JRNL REF TO BE PUBLISHED
JRNL REFN
REMARK 2
REMARK 2 RESOLUTION. 1.90 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNX 2005
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS
REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA,
REMARK 3 : YIP,DZAKULA)
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.90
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 6.00
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 455927.130
REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.8
REMARK 3 NUMBER OF REFLECTIONS : 37835
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.208
REMARK 3 R VALUE (WORKING SET) : 0.208
REMARK 3 FREE R VALUE : 0.230
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 10.000
REMARK 3 FREE R VALUE TEST SET COUNT : 3802
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.004
REMARK 3
REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA.
REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL
REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE (NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL
REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL
REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : NULL
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 10
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.90
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.97
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.40
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 3175
REMARK 3 BIN R VALUE (WORKING SET) : 0.2570
REMARK 3 BIN FREE R VALUE : 0.2930
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 10.30
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 363
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.015
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2957
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 35
REMARK 3 SOLVENT ATOMS : 261
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 21.40
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 31.00
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -6.86000
REMARK 3 B22 (A**2) : 12.76000
REMARK 3 B33 (A**2) : -5.91000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.21
REMARK 3 ESD FROM SIGMAA (A) : 0.11
REMARK 3 LOW RESOLUTION CUTOFF (A) : 6.00
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.24
REMARK 3 ESD FROM C-V SIGMAA (A) : 0.15
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.006
REMARK 3 BOND ANGLES (DEGREES) : 1.300
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.00
REMARK 3 IMPROPER ANGLES (DEGREES) : 0.770
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : BABINET
REMARK 3 KSOL : 0.80
REMARK 3 BSOL : 280.0
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM
REMARK 3 PARAMETER FILE 2 : S7396_INH_RB2_V2_EDIT.XPRM
REMARK 3 PARAMETER FILE 3 : ION.PARAM
REMARK 3 PARAMETER FILE 4 : WATER_REP.PARAM
REMARK 3 PARAMETER FILE 5 : NULL
REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP
REMARK 3 TOPOLOGY FILE 2 : WATER.TOP
REMARK 3 TOPOLOGY FILE 3 : ION.TOP
REMARK 3 TOPOLOGY FILE 4 : NULL
REMARK 3 TOPOLOGY FILE 5 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: BULK SOLVENT MODEL USED
REMARK 4
REMARK 4 2ZJM COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 12-MAR-08.
REMARK 100 THE DEPOSITION ID IS D_1000028054.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 11-OCT-04
REMARK 200 TEMPERATURE (KELVIN) : 180
REMARK 200 PH : 5.0
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 HF
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.54
REMARK 200 MONOCHROMATOR : NULL
REMARK 200 OPTICS : VARIMAX-HF OPTIC
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS V
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : D*TREK
REMARK 200 DATA SCALING SOFTWARE : D*TREK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40419
REMARK 200 RESOLUTION RANGE HIGH (A) : 1.900
REMARK 200 RESOLUTION RANGE LOW (A) : 50.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0
REMARK 200 DATA REDUNDANCY : NULL
REMARK 200 R MERGE (I) : 0.09400
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : NULL
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.90
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.97
REMARK 200 COMPLETENESS FOR SHELL (%) : NULL
REMARK 200 DATA REDUNDANCY IN SHELL : NULL
REMARK 200 R MERGE FOR SHELL (I) : 0.45400
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: AMORE
REMARK 200 STARTING MODEL: PDB ENTRY 2P8H
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 56.23
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.81
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES (PH 7.5), 1.5M LI2SO4, PH
REMARK 280 5.0, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 295K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,-Y,Z+1/2
REMARK 290 3555 -X,Y,-Z+1/2
REMARK 290 4555 X,-Y,-Z
REMARK 290 5555 X+1/2,Y+1/2,Z
REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2
REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2
REMARK 290 8555 X+1/2,-Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.28050
REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 38.28050
REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 51.82250
REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 63.91800
REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 51.82250
REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 63.91800
REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 38.28050
REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 51.82250
REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 63.91800
REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 38.28050
REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 51.82250
REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 63.91800
REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 429
REMARK 465 LEU A 430
REMARK 465 PRO A 431
REMARK 465 ARG A 432
REMARK 465 GLU A 433
REMARK 465 THR A 434
REMARK 465 ASP A 435
REMARK 465 GLU A 436
REMARK 465 GLU A 437
REMARK 465 PRO A 438
REMARK 465 GLU A 439
REMARK 465 GLU A 440
REMARK 465 PRO A 441
REMARK 465 GLY A 442
REMARK 465 ARG A 443
REMARK 465 ARG A 444
REMARK 465 GLY A 158
REMARK 465 PHE A 159
REMARK 465 PRO A 160
REMARK 465 LEU A 161
REMARK 465 ASN A 162
REMARK 465 GLN A 163
REMARK 465 SER A 164
REMARK 465 GLU A 165
REMARK 465 VAL A 166
REMARK 465 LEU A 167
REMARK 465 ALA A 168
REMARK 465 SER A 169
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 SER A 10 16.32 -52.94
REMARK 500 PHE A 108 -67.87 -105.48
REMARK 500 ASN A 114 -3.41 82.71
REMARK 500 ASP A 131 1.63 -69.30
REMARK 500 TRP A 197 -78.72 -144.29
REMARK 500 ASP A 223 -73.38 95.31
REMARK 500 LYS A 224 146.78 -176.77
REMARK 500 GLU A 310 99.84 -35.73
REMARK 500 ALA A 313 73.50 -176.24
REMARK 500 GLN A 316 33.23 -77.53
REMARK 500 THR A 329 -146.85 -138.76
REMARK 500 ASP A 363 -162.26 -129.36
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE F1M A 395
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 2ZJH RELATED DB: PDB
REMARK 900 RELATED ID: 2ZJI RELATED DB: PDB
REMARK 900 RELATED ID: 2ZJJ RELATED DB: PDB
REMARK 900 RELATED ID: 2ZJK RELATED DB: PDB
REMARK 900 RELATED ID: 2ZJL RELATED DB: PDB
REMARK 900 RELATED ID: 2ZJN RELATED DB: PDB
DBREF 2ZJM A 430 385 UNP P56817 BACE1_HUMAN 43 446
SEQADV 2ZJM MET A 429 UNP P56817 EXPRESSION TAG
SEQADV 2ZJM ALA A 75 UNP P56817 LYS 136 ENGINEERED MUTATION
SEQADV 2ZJM ALA A 77 UNP P56817 GLU 138 ENGINEERED MUTATION
SEQRES 1 A 405 MET LEU PRO ARG GLU THR ASP GLU GLU PRO GLU GLU PRO
SEQRES 2 A 405 GLY ARG ARG GLY SER PHE VAL GLU MET VAL ASP ASN LEU
SEQRES 3 A 405 ARG GLY LYS SER GLY GLN GLY TYR TYR VAL GLU MET THR
SEQRES 4 A 405 VAL GLY SER PRO PRO GLN THR LEU ASN ILE LEU VAL ASP
SEQRES 5 A 405 THR GLY SER SER ASN PHE ALA VAL GLY ALA ALA PRO HIS
SEQRES 6 A 405 PRO PHE LEU HIS ARG TYR TYR GLN ARG GLN LEU SER SER
SEQRES 7 A 405 THR TYR ARG ASP LEU ARG LYS GLY VAL TYR VAL PRO TYR
SEQRES 8 A 405 THR GLN GLY ALA TRP ALA GLY GLU LEU GLY THR ASP LEU
SEQRES 9 A 405 VAL SER ILE PRO HIS GLY PRO ASN VAL THR VAL ARG ALA
SEQRES 10 A 405 ASN ILE ALA ALA ILE THR GLU SER ASP LYS PHE PHE ILE
SEQRES 11 A 405 ASN GLY SER ASN TRP GLU GLY ILE LEU GLY LEU ALA TYR
SEQRES 12 A 405 ALA GLU ILE ALA ARG PRO ASP ASP SER LEU GLU PRO PHE
SEQRES 13 A 405 PHE ASP SER LEU VAL LYS GLN THR HIS VAL PRO ASN LEU
SEQRES 14 A 405 PHE SER LEU GLN LEU CYS GLY ALA GLY PHE PRO LEU ASN
SEQRES 15 A 405 GLN SER GLU VAL LEU ALA SER VAL GLY GLY SER MET ILE
SEQRES 16 A 405 ILE GLY GLY ILE ASP HIS SER LEU TYR THR GLY SER LEU
SEQRES 17 A 405 TRP TYR THR PRO ILE ARG ARG GLU TRP TYR TYR GLU VAL
SEQRES 18 A 405 ILE ILE VAL ARG VAL GLU ILE ASN GLY GLN ASP LEU LYS
SEQRES 19 A 405 MET ASP CYS LYS GLU TYR ASN TYR ASP LYS SER ILE VAL
SEQRES 20 A 405 ASP SER GLY THR THR ASN LEU ARG LEU PRO LYS LYS VAL
SEQRES 21 A 405 PHE GLU ALA ALA VAL LYS SER ILE LYS ALA ALA SER SER
SEQRES 22 A 405 THR GLU LYS PHE PRO ASP GLY PHE TRP LEU GLY GLU GLN
SEQRES 23 A 405 LEU VAL CYS TRP GLN ALA GLY THR THR PRO TRP ASN ILE
SEQRES 24 A 405 PHE PRO VAL ILE SER LEU TYR LEU MET GLY GLU VAL THR
SEQRES 25 A 405 ASN GLN SER PHE ARG ILE THR ILE LEU PRO GLN GLN TYR
SEQRES 26 A 405 LEU ARG PRO VAL GLU ASP VAL ALA THR SER GLN ASP ASP
SEQRES 27 A 405 CYS TYR LYS PHE ALA ILE SER GLN SER SER THR GLY THR
SEQRES 28 A 405 VAL MET GLY ALA VAL ILE MET GLU GLY PHE TYR VAL VAL
SEQRES 29 A 405 PHE ASP ARG ALA ARG LYS ARG ILE GLY PHE ALA VAL SER
SEQRES 30 A 405 ALA CYS HIS VAL HIS ASP GLU PHE ARG THR ALA ALA VAL
SEQRES 31 A 405 GLU GLY PRO PHE VAL THR LEU ASP MET GLU ASP CYS GLY
SEQRES 32 A 405 TYR ASN
HET F1M A 395 35
HETNAM F1M N-{1-[5-CHLORO-3-METHOXY-2-(1-METHYLETHOXY)
HETNAM 2 F1M BENZYL]PIPERIDIN-4-YL}-2-(4-SULFAMOYLPHENOXY)ACETAMIDE
HETSYN F1M N-[1-(5-CHLORO-2-ISOPROPOXY-3-METHOXY-BENZYL)-
HETSYN 2 F1M PIPERIDIN-4-YL]-2-(4-SULFAMOYL-PHENOXY)-ACETAMIDE
FORMUL 2 F1M C24 H32 CL N3 O6 S
FORMUL 3 HOH *261(H2 O)
HELIX 1 1 PHE A 447 VAL A 3 5 5
HELIX 2 2 GLN A 53 SER A 57 5 5
HELIX 3 3 TYR A 123 ALA A 127 5 5
HELIX 4 4 PRO A 135 THR A 144 1 10
HELIX 5 5 ASP A 180 SER A 182 5 3
HELIX 6 6 ASP A 216 TYR A 222 1 7
HELIX 7 7 LYS A 238 SER A 252 1 15
HELIX 8 8 PRO A 258 LEU A 263 1 6
HELIX 9 9 PRO A 276 PHE A 280 5 5
HELIX 10 10 LEU A 301 TYR A 305 1 5
HELIX 11 11 GLY A 334 GLU A 339 1 6
HELIX 12 12 ARG A 347 ARG A 349 5 3
HELIX 13 13 ASP A 378 GLY A 383 5 6
SHEET 1 A 9 ARG A 61 PRO A 70 0
SHEET 2 A 9 ALA A 75 SER A 86 -1 O LEU A 80 N LYS A 65
SHEET 3 A 9 TYR A 14 VAL A 20 -1 N THR A 19 O SER A 86
SHEET 4 A 9 LEU A 6 GLY A 8 -1 N ARG A 7 O TYR A 15
SHEET 5 A 9 GLY A 171 ILE A 176 -1 O GLY A 172 N LEU A 6
SHEET 6 A 9 PHE A 150 CYS A 155 -1 N GLN A 153 O SER A 173
SHEET 7 A 9 PHE A 341 ASP A 346 -1 O PHE A 345 N PHE A 150
SHEET 8 A 9 ARG A 351 SER A 357 -1 O GLY A 353 N VAL A 344
SHEET 9 A 9 TYR A 184 PRO A 192 -1 N THR A 191 O ILE A 352
SHEET 1 B13 ARG A 61 PRO A 70 0
SHEET 2 B13 ALA A 75 SER A 86 -1 O LEU A 80 N LYS A 65
SHEET 3 B13 VAL A 95 ASP A 106 -1 O ASP A 106 N ALA A 75
SHEET 4 B13 PHE A 38 GLY A 41 1 N VAL A 40 O ILE A 102
SHEET 5 B13 GLY A 117 GLY A 120 -1 O ILE A 118 N ALA A 39
SHEET 6 B13 GLN A 25 ASP A 32 1 N LEU A 30 O LEU A 119
SHEET 7 B13 TYR A 14 VAL A 20 -1 N VAL A 16 O ILE A 29
SHEET 8 B13 LEU A 6 GLY A 8 -1 N ARG A 7 O TYR A 15
SHEET 9 B13 GLY A 171 ILE A 176 -1 O GLY A 172 N LEU A 6
SHEET 10 B13 PHE A 150 CYS A 155 -1 N GLN A 153 O SER A 173
SHEET 11 B13 PHE A 341 ASP A 346 -1 O PHE A 345 N PHE A 150
SHEET 12 B13 ARG A 351 SER A 357 -1 O GLY A 353 N VAL A 344
SHEET 13 B13 TYR A 184 PRO A 192 -1 N THR A 191 O ILE A 352
SHEET 1 C 5 GLU A 200 VAL A 201 0
SHEET 2 C 5 SER A 225 VAL A 227 -1 O SER A 225 N VAL A 201
SHEET 3 C 5 VAL A 332 MET A 333 1 O MET A 333 N ILE A 226
SHEET 4 C 5 LEU A 234 PRO A 237 -1 N ARG A 235 O VAL A 332
SHEET 5 C 5 ILE A 324 SER A 327 1 O SER A 325 N LEU A 236
SHEET 1 D 5 GLN A 211 ASP A 212 0
SHEET 2 D 5 ILE A 203 ILE A 208 -1 N ILE A 208 O GLN A 211
SHEET 3 D 5 ILE A 283 MET A 288 -1 O TYR A 286 N ARG A 205
SHEET 4 D 5 GLN A 294 ILE A 300 -1 O ILE A 300 N ILE A 283
SHEET 5 D 5 ALA A 369 VAL A 375 -1 O ALA A 369 N THR A 299
SHEET 1 E 3 VAL A 268 GLN A 271 0
SHEET 2 E 3 ASP A 317 PHE A 322 -1 O ASP A 318 N TRP A 270
SHEET 3 E 3 LEU A 306 PRO A 308 -1 N ARG A 307 O LYS A 321
SSBOND 1 CYS A 155 CYS A 359 1555 1555 2.04
SSBOND 2 CYS A 217 CYS A 382 1555 1555 2.04
SSBOND 3 CYS A 269 CYS A 319 1555 1555 2.03
CISPEP 1 SER A 22 PRO A 23 0 -0.32
CISPEP 2 ARG A 128 PRO A 129 0 -0.32
CISPEP 3 GLY A 372 PRO A 373 0 -0.21
SITE 1 AC1 19 GLN A 12 LEU A 30 ASP A 32 GLY A 34
SITE 2 AC1 19 TYR A 71 PHE A 108 TRP A 115 TYR A 198
SITE 3 AC1 19 ILE A 226 ASP A 228 GLY A 230 THR A 231
SITE 4 AC1 19 ARG A 235 SER A 327 SER A 328 THR A 329
SITE 5 AC1 19 HOH A 463 HOH A 486 HOH A 648
CRYST1 103.645 127.836 76.561 90.00 90.00 90.00 C 2 2 21 8
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.009648 0.000000 0.000000 0.00000
SCALE2 0.000000 0.007823 0.000000 0.00000
SCALE3 0.000000 0.000000 0.013061 0.00000